224 related articles for article (PubMed ID: 22406619)
1. Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1.
Lu R; Kujawski M; Pan H; Shively JE
Cancer Res; 2012 May; 72(9):2239-50. PubMed ID: 22406619
[TBL] [Abstract][Full Text] [Related]
2. Bv8 regulates myeloid-cell-dependent tumour angiogenesis.
Shojaei F; Wu X; Zhong C; Yu L; Liang XH; Yao J; Blanchard D; Bais C; Peale FV; van Bruggen N; Ho C; Ross J; Tan M; Carano RA; Meng YG; Ferrara N
Nature; 2007 Dec; 450(7171):825-31. PubMed ID: 18064003
[TBL] [Abstract][Full Text] [Related]
3. Induction of Bv8 expression by granulocyte colony-stimulating factor in CD11b+Gr1+ cells: key role of Stat3 signaling.
Qu X; Zhuang G; Yu L; Meng G; Ferrara N
J Biol Chem; 2012 Jun; 287(23):19574-84. PubMed ID: 22528488
[TBL] [Abstract][Full Text] [Related]
4. Refractoriness to antivascular endothelial growth factor treatment: role of myeloid cells.
Shojaei F; Ferrara N
Cancer Res; 2008 Jul; 68(14):5501-4. PubMed ID: 18632597
[TBL] [Abstract][Full Text] [Related]
5. G-CSF-initiated myeloid cell mobilization and angiogenesis mediate tumor refractoriness to anti-VEGF therapy in mouse models.
Shojaei F; Wu X; Qu X; Kowanetz M; Yu L; Tan M; Meng YG; Ferrara N
Proc Natl Acad Sci U S A; 2009 Apr; 106(16):6742-7. PubMed ID: 19346489
[TBL] [Abstract][Full Text] [Related]
6. G-protein-coupled receptor agonist BV8/prokineticin-2 and STAT3 protein form a feed-forward loop in both normal and malignant myeloid cells.
Xin H; Lu R; Lee H; Zhang W; Zhang C; Deng J; Liu Y; Shen S; Wagner KU; Forman S; Jove R; Yu H
J Biol Chem; 2013 May; 288(19):13842-9. PubMed ID: 23548897
[TBL] [Abstract][Full Text] [Related]
7. Role of Bv8 in neutrophil-dependent angiogenesis in a transgenic model of cancer progression.
Shojaei F; Singh M; Thompson JD; Ferrara N
Proc Natl Acad Sci U S A; 2008 Feb; 105(7):2640-5. PubMed ID: 18268320
[TBL] [Abstract][Full Text] [Related]
8. CEACAM1+ myeloid cells control angiogenesis in inflammation.
Horst AK; Bickert T; Brewig N; Ludewig P; van Rooijen N; Schumacher U; Beauchemin N; Ito WD; Fleischer B; Wagener C; Ritter U
Blood; 2009 Jun; 113(26):6726-36. PubMed ID: 19273835
[TBL] [Abstract][Full Text] [Related]
9. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow.
Poh TW; Bradley JM; Mukherjee P; Gendler SJ
Cancer Res; 2009 Apr; 69(8):3554-62. PubMed ID: 19351842
[TBL] [Abstract][Full Text] [Related]
10. Acceleration of collateral development by carcinoembryonic antigen-related cell adhesion molecule 1 expression on CD11b/⁺Gr-1⁺ myeloid cells--brief report.
Bickert T; Marshall RP; Zhang Z; Ludewig P; Binder M; Klinke A; Rottbauer W; Amling M; Wagener C; Ito WD; Horst AK
Arterioscler Thromb Vasc Biol; 2012 Nov; 32(11):2566-8. PubMed ID: 22962327
[TBL] [Abstract][Full Text] [Related]
11. Carcinoembryonic antigen-related cell adhesion molecule 1 negatively regulates granulocyte colony-stimulating factor production by breast tumor-associated macrophages that mediate tumor angiogenesis.
Samineni S; Zhang Z; Shively JE
Int J Cancer; 2013 Jul; 133(2):394-407. PubMed ID: 23319418
[TBL] [Abstract][Full Text] [Related]
12. Vascular adhesion protein-1 enhances tumor growth by supporting recruitment of Gr-1+CD11b+ myeloid cells into tumors.
Marttila-Ichihara F; Auvinen K; Elima K; Jalkanen S; Salmi M
Cancer Res; 2009 Oct; 69(19):7875-83. PubMed ID: 19789345
[TBL] [Abstract][Full Text] [Related]
13. Tumor refractoriness to endostatin anti-angiogenesis is associated with the recruitment of CD11b+Gr1+ myeloid cells and inflammatory cytokines.
Zhang H; Wang Z; Peng Q; Liu YY; Zhang W; Wu L; Wang X; Luo F
Tumori; 2013; 99(6):723-33. PubMed ID: 24503797
[TBL] [Abstract][Full Text] [Related]
14. Tumor-derived IL-35 promotes tumor growth by enhancing myeloid cell accumulation and angiogenesis.
Wang Z; Liu JQ; Liu Z; Shen R; Zhang G; Xu J; Basu S; Feng Y; Bai XF
J Immunol; 2013 Mar; 190(5):2415-23. PubMed ID: 23345334
[TBL] [Abstract][Full Text] [Related]
15. An interleukin-17-mediated paracrine network promotes tumor resistance to anti-angiogenic therapy.
Chung AS; Wu X; Zhuang G; Ngu H; Kasman I; Zhang J; Vernes JM; Jiang Z; Meng YG; Peale FV; Ouyang W; Ferrara N
Nat Med; 2013 Sep; 19(9):1114-23. PubMed ID: 23913124
[TBL] [Abstract][Full Text] [Related]
16. Suppressing neutrophil-dependent angiogenesis abrogates resistance to anti-VEGF antibody in a genetic model of colorectal cancer.
Itatani Y; Yamamoto T; Zhong C; Molinolo AA; Ruppel J; Hegde P; Taketo MM; Ferrara N
Proc Natl Acad Sci U S A; 2020 Sep; 117(35):21598-21608. PubMed ID: 32817421
[TBL] [Abstract][Full Text] [Related]
17. GM-CSF is one of the main breast tumor-derived soluble factors involved in the differentiation of CD11b-Gr1- bone marrow progenitor cells into myeloid-derived suppressor cells.
Morales JK; Kmieciak M; Knutson KL; Bear HD; Manjili MH
Breast Cancer Res Treat; 2010 Aug; 123(1):39-49. PubMed ID: 19898981
[TBL] [Abstract][Full Text] [Related]
18. Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer.
Arabzadeh A; Chan C; Nouvion AL; Breton V; Benlolo S; DeMarte L; Turbide C; Brodt P; Ferri L; Beauchemin N
Oncogene; 2013 Feb; 32(7):849-60. PubMed ID: 22469976
[TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived suppressor cells contribute to A2B adenosine receptor-induced VEGF production and angiogenesis in a mouse melanoma model.
Sorrentino C; Miele L; Porta A; Pinto A; Morello S
Oncotarget; 2015 Sep; 6(29):27478-89. PubMed ID: 26317647
[TBL] [Abstract][Full Text] [Related]
20. Premetastatic soil and prevention of breast cancer brain metastasis.
Liu Y; Kosaka A; Ikeura M; Kohanbash G; Fellows-Mayle W; Snyder LA; Okada H
Neuro Oncol; 2013 Jul; 15(7):891-903. PubMed ID: 23595625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
